EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 254 filers reported holding EXELIXIS INC in Q2 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,409,000 | -37.3% | 46,361 | -50.0% | 0.05% | +9.3% |
| Q3 2017 | $2,246,000 | +96.7% | 92,722 | +100.0% | 0.04% | -24.6% |
| Q2 2017 | $1,142,000 | +13.6% | 46,361 | 0.0% | 0.06% | 0.0% |
| Q1 2017 | $1,005,000 | +45.4% | 46,361 | 0.0% | 0.06% | +16.3% |
| Q4 2016 | $691,000 | -49.0% | 46,361 | -88.4% | 0.05% | -63.2% |
| Q2 2014 | $1,356,000 | -4.2% | 400,000 | 0.0% | 0.13% | -10.7% |
| Q1 2014 | $1,416,000 | – | 400,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |